Cargando…

The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients

BACKGROUND: The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed. The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of...

Descripción completa

Detalles Bibliográficos
Autores principales: Millares, Laura, Bermudo, Guadalupe, Pérez-Brocal, Vicente, Domingo, Christian, Garcia-Nuñez, Marian, Pomares, Xavier, Moya, Andrés, Monsó, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248442/
https://www.ncbi.nlm.nih.gov/pubmed/28103814
http://dx.doi.org/10.1186/s12866-017-0933-6
_version_ 1782497267725369344
author Millares, Laura
Bermudo, Guadalupe
Pérez-Brocal, Vicente
Domingo, Christian
Garcia-Nuñez, Marian
Pomares, Xavier
Moya, Andrés
Monsó, Eduard
author_facet Millares, Laura
Bermudo, Guadalupe
Pérez-Brocal, Vicente
Domingo, Christian
Garcia-Nuñez, Marian
Pomares, Xavier
Moya, Andrés
Monsó, Eduard
author_sort Millares, Laura
collection PubMed
description BACKGROUND: The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed. The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of patients with severe chronic asthma chronically treated with corticosteroids in addition to usual care according to Global Initiative for Asthma. Bacterial community composition was obtained by 16S rRNA gene amplification and sequencing, and functional capabilities through PICRUSt. RESULTS: Thirteen patients with severe asthma were included and provided 11 bronchial biopsies (BB) and 12 bronchial aspirates (BA) suitable for sequence analyses. Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria showed relative abundances (RAs) over 5% in BB, a cutoff that was reached by Streptococcus and Prevotella at genus level. Legionella genus attained a median RA of 2.7 (interquartile range 1.1–4.7) in BB samples. In BA a higher RA of Fusobacteria was found, when compared with BB [8.7 (5.9–11.4) vs 4.2 (0.8–7.5), p = 0.037], while the RA of Proteobacteria was lower in BA [4.3 (3.7–6.5) vs 17.1 (11.2–33.4), p = 0.005]. RA of the Legionella genus was also significantly lower in BA [0.004 (0.001–0.02) vs. 2.7 (1.1–4.7), p = 0.005]. Beta-diversity analysis confirmed the differences between the microbial communities in BA and BB (R(2) = 0.20, p = 0.001, Adonis test), and functional analysis revealed also statistically significant differences between both types of sample on Metabolism, Cellular processes, Human diseases, Organismal systems and Genetic information processing pathways. CONCLUSIONS: The microbiota in the bronchial mucosa of severe asthma has a specific pattern that is not accurately represented in bronchial secretions, which must be considered a different niche of bacteria growth. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-017-0933-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5248442
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52484422017-01-25 The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients Millares, Laura Bermudo, Guadalupe Pérez-Brocal, Vicente Domingo, Christian Garcia-Nuñez, Marian Pomares, Xavier Moya, Andrés Monsó, Eduard BMC Microbiol Research Article BACKGROUND: The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed. The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of patients with severe chronic asthma chronically treated with corticosteroids in addition to usual care according to Global Initiative for Asthma. Bacterial community composition was obtained by 16S rRNA gene amplification and sequencing, and functional capabilities through PICRUSt. RESULTS: Thirteen patients with severe asthma were included and provided 11 bronchial biopsies (BB) and 12 bronchial aspirates (BA) suitable for sequence analyses. Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria showed relative abundances (RAs) over 5% in BB, a cutoff that was reached by Streptococcus and Prevotella at genus level. Legionella genus attained a median RA of 2.7 (interquartile range 1.1–4.7) in BB samples. In BA a higher RA of Fusobacteria was found, when compared with BB [8.7 (5.9–11.4) vs 4.2 (0.8–7.5), p = 0.037], while the RA of Proteobacteria was lower in BA [4.3 (3.7–6.5) vs 17.1 (11.2–33.4), p = 0.005]. RA of the Legionella genus was also significantly lower in BA [0.004 (0.001–0.02) vs. 2.7 (1.1–4.7), p = 0.005]. Beta-diversity analysis confirmed the differences between the microbial communities in BA and BB (R(2) = 0.20, p = 0.001, Adonis test), and functional analysis revealed also statistically significant differences between both types of sample on Metabolism, Cellular processes, Human diseases, Organismal systems and Genetic information processing pathways. CONCLUSIONS: The microbiota in the bronchial mucosa of severe asthma has a specific pattern that is not accurately represented in bronchial secretions, which must be considered a different niche of bacteria growth. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-017-0933-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-19 /pmc/articles/PMC5248442/ /pubmed/28103814 http://dx.doi.org/10.1186/s12866-017-0933-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Millares, Laura
Bermudo, Guadalupe
Pérez-Brocal, Vicente
Domingo, Christian
Garcia-Nuñez, Marian
Pomares, Xavier
Moya, Andrés
Monsó, Eduard
The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
title The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
title_full The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
title_fullStr The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
title_full_unstemmed The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
title_short The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
title_sort respiratory microbiome in bronchial mucosa and secretions from severe ige-mediated asthma patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248442/
https://www.ncbi.nlm.nih.gov/pubmed/28103814
http://dx.doi.org/10.1186/s12866-017-0933-6
work_keys_str_mv AT millareslaura therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT bermudoguadalupe therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT perezbrocalvicente therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT domingochristian therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT garcianunezmarian therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT pomaresxavier therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT moyaandres therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT monsoeduard therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT millareslaura respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT bermudoguadalupe respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT perezbrocalvicente respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT domingochristian respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT garcianunezmarian respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT pomaresxavier respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT moyaandres respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients
AT monsoeduard respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients